Mike Thompson, MD, PhD

18 Followers

*Regarding LinkedIn* I generally don't connect with people on LinkedIn that don't comment on why they think we should connect. See: Use the “Favor Test” When You're Undecided About a LinkedIn Invitation [7/13/13] - @awsamuel @lifehacker http://ow.ly/AucoV ----------- I am a board certified hematologist / oncologist. I am passionate about clinical trials, basic science and translational research. It is a tragedy that only 2-7% of adults participate in cancer clinical trials (Zon R. et al. ASCO statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol. 2008) Improved clinical trial enrollment depends on well designed, interesting trials as well as inf

#leusm social media #ebmt16 #lymsm bone marrow transplant #bmtsm #mmsm #hcsm #mpnsm

Activity
About

Mike Thompson, MD, PhD

Presentations

#EBMT16 - Social Media in Hematology / Oncology / BMT

Likes

Primer on using Snapchat at #AACR17 and other scientific meetings

Cancer Care in a Post Truth World

Three things to know about pharma and twitter

Revealing ASCO's social DNA

Biosimilars discussion on Twitter

#radonc Journal Club on Twitter

Digital Media Trends: Audience Architecture

Social Media And Ethical Concerns For Healthcare Professionals

The evolution of online cancer conversations

SEOR 2015: Hashtags, #radonc and building community

Disease specific hashtags for communication about cancer care

Why Do We Need Twitter? For Health Professionals In Oncology, Hematology & Transplant

A healthcare case study of ASCO, Novartis and Boehringer conversation on twitter

Social media and medicine

Medical professionalism 10 20

Getting started in social media for healthcare professionals

Twitter 101 Signing up: A Tutorial for Oncologists

Twitter 102 Account Settings

Twitter 103 Trolls, Malware and Spam